Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Classic Psychedelic

or Dissociative

or [[:Category:Vitamin_D_analogs|Vitamin D analog (active form)]]

Use the filters below to narrow your results.

None (86) · Delysid (historical, Sandoz, withdrawn 1965) (1) · DXM (1) · DXO (1) · Rocaltrol (oral), Calcijex (IV); topical Vectical for psoriasis (1) · Spravato (1)

5-HT2A agonist (26) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · NMDA antagonist (3) · None (2) · Contains LSA (2) · Contains mescaline (2) · NMDA antagonist; sigma receptor agonist (2)

Other values:

None (89) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1) · '"`UNIQ--vote-0000115F-QINU`"', '"`UNIQ--vote-00001160-QINU`"', '"`UNIQ--vote-00001161-QINU`"', '"`UNIQ--vote-00001162-QINU`"', '"`UNIQ--vote-00001163-QINU`"' (1)

None (89) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1) · Oral 0.25 mcg daily, titrate by serum calcium and PTH; IV in CKD 0.5-3 mcg three times weekly (1)

None (89) · 0.25, 0.5 mcg oral capsules; 1 mcg/mL oral solution; 1 mcg/mL IV; 3 mcg/g topical ointment (1) · 28 mg/device (each dose uses 2 devices) (1)

None (89) · 84 mg per session (1) · Titrated; risk of hypercalcemia is the limiting factor (1)

None (88) · Intranasal (under direct medical supervision) (1) · IV (1) · Oral (2) · topical (1)

None (88) · 30–60 minutes (1) · Days for calcium effect; weeks for PTH suppression (1) · Within hours of first administration (1)

None (88) · 8–12 hours (1) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1) · Hours per dose (much shorter biologic effect than ergocalciferol/cholecalciferol because it is the already-active form, not the storage form) (1)

None (88) · 3–5 hours (1) · ~5-8 hours'"`UNIQ--ref-00001164-QINU`"' (1) · ~7-12 hours (1)

None (88) · 70–90% (oral) (1) · High (oral)'"`UNIQ--ref-00001165-QINU`"' (1) · ~48% intranasal (1)

None (88) · Avoid; may cause fetal harm (1) · Not established (1) · Used when needed for hypoparathyroidism or renal osteodystrophy in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

None (88) · Rx, Schedule III (US). REMS program required. (1) · Schedule I (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 91 results in range #1 to #91.

1

2

3

4

5

A

B

C

Calcitriol

D

E

H

Hawaiian Baby Woodrose

I

Ibogaine

L

M

N

Nitrous oxide

O

O-PCE

P

S

T

TMA-2

X

Xenon

Y

Yopo

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"